Vera Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview

Vera Therapeutics

07/05/2024 13:19

* Vera Therapeutics Inc  VERA.OQ   VERA.O  is expected
to show no
change in quarterly revenue when it reports  results on May 9
(estimated) for the period ending January 1 0001
    * 
    * ​LSEG's mean analyst estimate for Vera Therapeutics Inc is
for a
loss of 53 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 0.2%
in the last three months. ​
    * Wall Street's median 12-month price target for Vera
Therapeutics
Inc is $54.50​, above​ its last closing price of $45.54. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.53       -0.51      -0.60     Missed  -18.2
 Sep. 30 2023  -0.53       -0.53      -0.45     Beat    15.6
 Jun. 30 2023  -0.70       -0.69      -0.46     Beat    33.7​
 Jan. 1 0001   -0.60       -0.60      -0.80     Missed  -32.4
 ​​Dec.                    -0.90      -1.18     Missed  -30.6
 31 2022                                                
 Sep. 30 2022  -0.67       -0.72      -0.91     Missed  -26.1​
 Jun. 30 2022  -0.72       -0.72      -0.55     Beat    23.4
 Mar. 31 2022  -0.67       -0.67      -0.71     Missed  -6
 This summary was machine generated May 7 at 12:19 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)